Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM

Todd Neale

September 15, 2022

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Todd Neale

May 31, 2022

Presentation ACC 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presenter: Milind Y Desai

April 03, 2022

News Conference News ACC 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

Shelley Wood

May 15, 2021

News Conference News ESC 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

News Daily News

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

Yael L. Maxwell

July 11, 2019

News Daily News

基因检测不一定是 HCM 诊断的最后一根稻草

Yael L. Maxwell

August 23, 2016

News Daily News

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Yael L. Maxwell

August 23, 2016

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

Presentation TCT 2014

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Israel Guerrero Mantilla, MD

September 16, 2014

Presentation TCT 2014

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Malek Al-Hawwas, MD

September 16, 2014

Presentation TCT 2014

Interventional Perspective: Not Surgery of Course!

Presenter: Carey D. Kimmelstiel

September 16, 2014

Presentation TCT 2014

Surgeon's Perspective on HOCM surgery

Presenter: John D. Puskas

September 16, 2014

Presentation TCT 2014

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Complications of Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Patient Management Post Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh, Valerian Fernandes

September 16, 2014

Presentation TCT 2014

Case Selection and Use of Myocardial Contrast Echocardiography During Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Advertisement

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

‘Enormous’ QoL Improvements With Mavacamten in HCM

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

基因检测不一定是 HCM 诊断的最后一根稻草

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Interventional Perspective: Not Surgery of Course!

Surgeon's Perspective on HOCM surgery

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Complications of Alcohol Septal Ablation

Patient Management Post Ablation

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Case Selection and Use of Myocardial Contrast Echocardiography During Ablation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content